Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
In the latest session, Cg Oncology Inc (NASDAQ: CGON) closed at $38.82 up 2.92% from its previous closing price of $37.72. In other words, the price has increased by $2.92 from its previous closing price. On the day, 1.25 million shares were traded. CGON stock price reached its highest trading level at $39.15 during the session, while it also had its lowest trading level at $38.185.
Ratios:
For a deeper understanding of Cg Oncology Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 22.15 and its Current Ratio is at 22.15. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The Stock’s future direction. In the most recent recommendation for this company, Piper Sandler on August 19, 2025, initiated with a Overweight rating and assigned. The Stock a target price of $55.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 18 ’25 when JAMES MULAY bought 35,441 shares for $37.72 per share.
POST LEONARD E sold 1,000 shares of CGON for $35,100 on Sep 15 ’25. The Director now owns 0 shares after completing the transaction at $35.10 per share. On Sep 15 ’25, another insider, LEONARD E POST, who serves as the Director of the company, bought 3,000 shares for $33.34 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CGON now has a Market Capitalization of 2959931136 and an Enterprise Value of 2299873024. For. The Stock, the TTM Price-to-Sale (P/S) ratio is 5381.70 while its Price-to-Book (P/B) ratio in mrq is 4.41. Its current Enterprise Value per Revenue stands at 4173.998 whereas that against EBITDA is -14.641.
Stock Price History:
The Beta on a monthly basis for CGON is 0.99, which has changed by -0.0046153665 over the last 52 weeks, in comparison to a change of 0.16298151 over the same period for the S&P500. Over the past 52 weeks, CGON has reached a high of $40.47, while it has fallen to a 52-week low of $14.80. The 50-Day Moving Average of. The Stock is 38.57%, while the 200-Day Moving Average is calculated to be 43.14%.
Shares Statistics:
For the past three months, CGON has traded an average of 919.14K shares per day and 1591730 over the past ten days. A total of 76.23M shares are outstanding, with a floating share count of 45.56M. Insiders hold about 38.27% of the company’s shares, while institutions hold 77.36% stake in the company. Shares short for CGON as of 1756425600 were 10232411 with a Short Ratio of 11.13, compared to 1753920000 on 11004280. Therefore, it implies a Short% of Shares Outstanding of 10232411 and a Short% of Float of 14.21.
Earnings Estimates
. The Stock of Cg Oncology Inc (CGON) is currently in the spotlight, with 9.0 analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is -$0.56, with high estimates of -$0.43 and low estimates of -$0.67.
Analysts are recommending an EPS of between -$1.75 and -$2.3 for the fiscal current year, implying an average EPS of -$2.06. EPS for the following year is -$2.12, with 9.0 analysts recommending between -$0.9 and -$3.8.
